Search
Searching Content from China indexed under Life Sciences, Biotechnology & Nanotechnology ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5  
>>Next
 
Title
Country
Organisation
Author
Date
1
改革动作频频,千亿医疗器械市场面临机遇和挑战
近几个月来医疗器械行业内改革动作频频。医疗器械注册人制度试点扩大到21个省,有如释放行业创新活力的一剂良方,监管方通过将产研分开&#
China
22 Aug 2019
2
China's Central Government Introduces Major Policy Incentives And Restraints To The MedTech Industry
After continuously reshaping the competitive landscape in the pharmaceutical industry for several years, the Chinese government finally shifted its attention to the medtech industry.
China
21 Aug 2019
3
New Human Genetic Resources Regulations In China
On 28 May 2019, the People's Republic of China State Council promulgated the People's Republic of China Human Genetic Resources
China
23 Jul 2019
4
Chinese government releases new regulation on human genetic resources
Anyone who collects, preserves, utilizes or provides China's human genetic resources should comply with the regulations.
China
9 Jul 2019
5
China's State Council Publishes New Regulations On The Management Of Human Genetic Resources
China's State Council, the country's top administrative authority, released a new Regulation of Human Genetic Resources1 (the "Regulation") on May 28, 2019, to replace the tentative rules issued
China
26 Jun 2019
6
Survival Of The Fittest Or Cheapest?
T he past year is set to be a milestone year for China's pharmaceutical regulatory reform as the newly formed National Medical Products Administration (NMPA) continues to aggressively cut back on red
China
4 Jun 2019
7
China's SAMR Fines Hunan Er-Kang And Henan Jiushi CNY 10 Million For Unfair Pricing Of Chlorpheniramine API
On 30 December 2018, China's State Administration for Market Regulation (SAMR) issued an infringement decision imposing a total fine of CNY 10.04 million
China
5 Feb 2019
8
China Aims To Introduce Routine Drug And Device Overseas Inspections
China's drug and device regulator recently announced a set of rules signaling increased scrutiny of foreign drug and device companies.
China
18 Jan 2019
9
新的CFIUS试点计划:生命科学公司和投资者须知
如许多生命科学公司和投资者所知,美国财政部("财政部")最近对美国外国投资委员会("CFIUS")公布了一项新的"试点计划",
China
15 Nov 2018
10
China Continues To Sharpen Its Teeth Against Corruption: Updates To China's Anti-Corruption Regime
The first half of 2018 saw a number of significant changes to the Chinese anti-corruption regime, including amendments to the Anti-Unfair Competition Law and formation of new anti-corruption regulatory bodies.
China
18 Sep 2018
11
The Impact Of Scientific Data Administrative Measures On Foreign Companies In China
On March 17, 2018, the Chinese State Council passed the Scientific Data Administrative Measures (the "Measures") to standardize the management of scientific data at a national level.
China
17 Aug 2018
12
Major Medical Device Changes In China Introduced By The 2018 Draft Amendment To The "Regulations On The Supervision And Administration Of Medical Device"*
Following the issuance of the "Opinions on Deepening the Reform of Examination and Approval System and Encouraging Innovation in the Industries of Pharmaceuticals and Medical Devices"
China
16 Aug 2018
13
China's New Medical Device Regulations Bring Big Changes
The current MDR requires medtech companies to either conduct clinical studies in China or submit clinical evaluation reports illustrating equivalence to previously approved products
China
31 Jul 2018
14
Roche Winning The Reagent Kit Patent Infringement Case In Shanghai
Since it was founded in 1896, Roche has grown decade upon decade into a world-leading healthcare company, focused on developing medicines and diagnostics to help patients live longer, better lives.
China
12 Jul 2018
15
Continental Drift: SIPO's April 2017 Examination Guidelines Bring Significantly Improved Alignment With EU And US Rules In Software And Pharma Fields
The Chinese State Intellectual Property Office has significantly revised its examination guidelines with respect to inventions relating to business methods and software, submission of post-filing data...
China
22 May 2018
16
What Companies Need To Know About China's New Market Regulator
On March 17, China's highest legislative body, the National People's Congress, approved a sweeping government restructuring plan.
China
19 Apr 2018
17
China Announces New Initiatives To Level The Playing Field For Innovative And Generic Drugs
China's Government will launch several incentives to enhance accessibility of innovative drugs, especially imported oncology drugs.
China
17 Apr 2018
18
China's New State Market Regulatory Administration: What To Know And What To Expect
On March 17, China's highest legislative body, the National People's Congress, approved a sweeping government restructuring plan.
China
6 Apr 2018
19
China FDA Releases Guidance On Acceptance Of Foreign Medical Device Study Data
On January 10, 2018, the China Food and Drug Administration announced the implementation of the Technical Guidelines Governing Acceptance of Medical Device Clinical Data from Foreign Studies.
China
22 Jan 2018
20
China's Recent Development On Granting Biological Sequence Claims
Life sciences and biotechnology are widely regarded as one of the most promising frontier technologies for the coming decades.
China
9 Jan 2018
Links to Result pages
 
1 2 3 4 5  
>>Next